Lighthouse Investment Partners LLC acquired a new stake in The Procter & Gamble Company (NYSE:PG - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 34,146 shares of the company's stock, valued at approximately $5,725,000.
Several other institutional investors and hedge funds have also recently bought and sold shares of PG. NewSquare Capital LLC grew its position in shares of Procter & Gamble by 933.3% during the 4th quarter. NewSquare Capital LLC now owns 155 shares of the company's stock valued at $26,000 after buying an additional 140 shares during the last quarter. Navigoe LLC bought a new position in Procter & Gamble during the 4th quarter worth $31,000. Hoey Investments Inc. increased its position in Procter & Gamble by 321.7% in the fourth quarter. Hoey Investments Inc. now owns 194 shares of the company's stock worth $33,000 after buying an additional 148 shares during the period. LFA Lugano Financial Advisors SA bought a new stake in Procter & Gamble in the fourth quarter valued at $34,000. Finally, Atlantic Private Wealth LLC grew its position in shares of Procter & Gamble by 95.3% during the fourth quarter. Atlantic Private Wealth LLC now owns 207 shares of the company's stock worth $35,000 after acquiring an additional 101 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.
Procter & Gamble Price Performance
Shares of NYSE:PG traded up $0.87 on Friday, reaching $163.28. 7,100,112 shares of the company traded hands, compared to its average volume of 7,226,242. The stock has a market capitalization of $382.82 billion, a PE ratio of 26.00, a P/E/G ratio of 3.76 and a beta of 0.41. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.76 and a quick ratio of 0.55. The company's 50 day moving average is $164.50 and its 200-day moving average is $167.29. The Procter & Gamble Company has a fifty-two week low of $156.58 and a fifty-two week high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Thursday, April 24th. The company reported $1.54 EPS for the quarter, beating the consensus estimate of $1.53 by $0.01. The business had revenue of $19.78 billion during the quarter, compared to the consensus estimate of $20.42 billion. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. Procter & Gamble's revenue was down 2.1% compared to the same quarter last year. During the same period in the prior year, the business posted $1.52 earnings per share. As a group, analysts anticipate that The Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Monday, April 21st were given a $1.0568 dividend. This is an increase from Procter & Gamble's previous quarterly dividend of $1.01. This represents a $4.23 annualized dividend and a dividend yield of 2.59%. The ex-dividend date of this dividend was Monday, April 21st. Procter & Gamble's dividend payout ratio (DPR) is 66.98%.
Analysts Set New Price Targets
A number of equities research analysts have recently weighed in on PG shares. Bank of America cut their price target on Procter & Gamble from $190.00 to $180.00 and set a "buy" rating on the stock in a report on Friday, April 25th. Truist Financial cut their target price on Procter & Gamble from $185.00 to $180.00 and set a "buy" rating on the stock in a research note on Friday, April 25th. Barclays reissued an "equal weight" rating on shares of Procter & Gamble in a research note on Thursday, March 27th. UBS Group restated a "buy" rating on shares of Procter & Gamble in a research note on Monday, February 10th. Finally, Morgan Stanley set a $180.00 target price on shares of Procter & Gamble and gave the company an "overweight" rating in a research report on Friday, April 25th. Eight investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $178.52.
View Our Latest Report on PG
Insider Activity
In other news, insider Moses Victor Javier Aguilar sold 10,520 shares of Procter & Gamble stock in a transaction on Monday, May 5th. The stock was sold at an average price of $158.67, for a total transaction of $1,669,208.40. Following the transaction, the insider now owns 25,182 shares in the company, valued at approximately $3,995,627.94. The trade was a 29.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Jennifer L. Davis sold 1,000 shares of the stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total value of $161,380.00. Following the completion of the sale, the chief executive officer now directly owns 51,965 shares of the company's stock, valued at approximately $8,386,111.70. This represents a 1.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 64,520 shares of company stock worth $10,999,268 over the last 90 days. 0.18% of the stock is owned by company insiders.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
